Generate a tailored SOP for Dr. Kathryn Whitehead. Improve your application with a focused, well-structured draft.
Kathryn Whitehead is a Professor at Carnegie Mellon University, where she also serves as the Director of Graduate Studies within the College of Engineering. Her research focuses on the development of drug delivery systems, particularly utilizing RNA and proteins to address challenges in maternal and infant health. Whitehead has obtained both her bachelor’s and doctoral degrees in Chemical Engineering, awarded by the University of Delaware and the University of California, Santa Barbara, respectively. She completed a NIH Postdoctoral Fellowship at MIT. Her contributions to the field have earned her numerous accolades, including the NIH Director’s New Innovator Award, the DARPA Director’s Fellowship, and the ASEE Curtis W. McGraw Research Award. In addition, she received the Controlled Release Society’s Young Investigator Award and has served on its Board of Directors. Whitehead has been elected as a Fellow of the American Institute for Medical and Biological Engineering and the Controlled Release Society. In 2021, she delivered a TED talk discussing the role of lipid nanoparticles in COVID-19 mRNA vaccines. Her publications have been cited approximately 15,000 times, and she holds patents that are licensed for therapeutic use.
Carnegie Mellon University • Pittsburgh, PA
Conducting advanced research in drug delivery systems and leading graduate studies.
Admission is extremely competitive with no strict GPA cut-offs; holistic review is used.